XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaborative Arrangements - Ridgeback Biotherapeutics LP (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 15,775 $ 14,487  
Cost of sales 3,540 3,926  
Selling, general and administrative 2,483 2,479  
Accrued and other current liabilities 14,102   $ 15,766
Ridgeback Biotherapeutics LP | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cost of sales 191 221  
Selling, general and administrative 16 27  
Research and development expense (credit) (5) 16  
Accrued and other current liabilities 160   $ 113
Ridgeback Biotherapeutics LP | Lagevrio | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Sales $ 350 $ 392